Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells

Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells

US Patent 12037357 · Granted Jul 16, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thienyl-aniline compounds for treatment of dermal disorders2025
Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-am2025
Pyrrolopyridine-aniline compounds for treatment of dermal disorders2025
Naphthyridinone-aniline compounds for treatment of dermal disorders2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2025
Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-am2025
EP2 antagonist compounds2025
Analogs of xanomeline2025
Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone2025
Pyrrolopyridine-aniline compounds for treatment of dermal disorders2024
Substituted isoquinolines as rock kinase inhibitors2024
N,N-dimethyltryptamine and related psychedelics and uses thereof2024